These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31235128)

  • 1. Factors associated with therapeutic target achievement in the control of complications in consequence of diabetes: A hospital-based study in west of Iran.
    Barzkar H; Nikbakht HA; Zeinolabedini M; Babazadeh T; Hassanipour S; Ghaffari-Fam S
    Diabetes Metab Syndr; 2019; 13(3):2009-2013. PubMed ID: 31235128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing quality care for children and adolescents with diabetes from lower-income families in Mexico.
    Mota-Oropeza ME; Bartley HE; Hernández-Pérez ND; Lara AG; Vázquez-López NA; Flores MF; Velázquez MM; Castañeda-Saldivar MJ; Middlehurst AC; Jenkins AJ; Ogle GD
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1139-1146. PubMed ID: 31483761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
    Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
    Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients.
    Bener A; Al-Hamaq AO; Kurtulus EM; Abdullatef WK; Zirie M
    Diabetes Metab Syndr; 2016; 10(4):198-204. PubMed ID: 27381964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
    Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
    Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoprotein.
    Megson IL; Treweeke AT; Shaw A; MacRury SM; Setford S; Frias JP; Anhalt H
    J Diabetes Sci Technol; 2015 May; 9(3):573-80. PubMed ID: 25652563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
    Orr CJ; Hopman W; Yen JL; Houlden RL
    Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
    Krzymień J; Kobli T; Nazar M
    Pol Arch Med Wewn; 2010 Nov; 120(11):444-50. PubMed ID: 21102380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
    Giampietro O; Giampietro C; Bartola LD; Masoni MC; Matteucci E
    Drug Des Devel Ther; 2013; 7():99-104. PubMed ID: 23439744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of therapeutic targets in Mexican patients with diabetes mellitus.
    Lavalle-González FJ; Chiquete E; de la Luz J; Ochoa-Guzmán A; Sánchez-Orozco LV; Godínez-Gutiérrez SA;
    Endocrinol Nutr; 2012 Dec; 59(10):591-8. PubMed ID: 23137765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients.
    Afkhami-Ardekani M; Shojaoddiny-Ardekani A
    Indian J Med Res; 2007 Nov; 126(5):471-4. PubMed ID: 18160753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with withdrawal from insulin pump therapy: A large-population-based study.
    Merzon E; Grossman J; Vinker S; Merhasin I; Levit S; Golan-Cohen A
    Diabetes Metab Res Rev; 2020 May; 36(4):e3288. PubMed ID: 31922314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.